drugset / Trial / NCT00934791
Polycystic Liver Disease in Kidney Transplant
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to see if one kind of immunosuppressive drug has better effects for the patient's polycystic liver disease than another type. Tacrolimus and Sirolimus are the two immunosuppressive drugs that will be compared for this study. Both drugs have been commonly prescribed to prevent rejection.
Timeline
- Start
- 2009-02
- Primary completion
- 2012-12
- Completion
- 2012-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Sirolimus | Small molecule | 3 mg | — |
| Comparator | Sirolimus | Small molecule | 5 mg | — |
| Comparator | Tacrolimus | Small molecule | 6 mg | — |
| Comparator | Tacrolimus | Small molecule | 10 mg | — |
| Comparator | Mycophenolate Mofetil | Small molecule | 750 mg | — |
| Comparator | Prednisone | Other / unclassified | 5 mg | — |